© Reuters
Johnson & Johnson faulted lax cleaning procedures and other problems at a manufacturing plant behind massive recalls of medicines like Tylenol, and said it was recalling nearly 50 million more bottles and packages of consumer medicines.
The healthcare company's reputation has been tarnished by repeated recalls totaling nearly 200 million bottles in the last year and it could face criminal charges from the U.S. Department of Justice.
Johnson & Johnson is now recalling bottles and packages of various kinds of Tylenol, Benadryl, Rolaids and other consumer products, it said on Friday.
J&J said the new recall followed a review of records dating back to 2007 of products made by its McNeil consumer healthcare unit, which produces most of the recalled medicines sold in the United States.
While the company said it had identified a number of areas for improvement, on Friday it disclosed only the cleaning problem and a minor labeling irregularity.
The company investigation found insufficient equipment cleaning procedures and instances where people failed to adequately document cleaning at McNeil's Fort Washington, Pa. plant, the company said. J&J suspended production there last April to address quality control lapses.
McNeil also found one product with a label that did not include all the information required by regulators, J&J said.
Comment: The title of this article should be: "Antibiotics CAUSE IBS and Crohn's disease in children in later life"